BondBloxx Bloomberg Twenty Year Target Duration US Treasury ETF (XTWY)
Live price chart, market sentiment, and community perspectives for BondBloxx Bloomberg Twenty Year Target Duration US Treasury ETF (AMEX: XTWY).
Live price chart, market sentiment, and community perspectives for BondBloxx Bloomberg Twenty Year Target Duration US Treasury ETF (AMEX: XTWY).
On our macro trading desk, we are keeping a close eye on XTWY's positioning. The fund offers an appealing 5.31% Yield to Maturity coupled with a lean 0.125% expense ratio, which keeps overhead low for long-duration exposure. However, looking at the recent market data, we've noted erratic short interest movements—such as the sharp spike up to 7,343 shares in July 2026 after a deep decline in June. While short interest remains a tiny fraction of total shares, these wild swings paired with an average daily volume around 23,000 to 52,000 shares tell us that liquidity and tactical hedging demand are worth monitoring closely before scaling up positions.
From a quantitative risk perspective, XTWY demands respect. Morningstar places its portfolio risk score at 67, placing it firmly in the 'Aggressive' bucket with a standard deviation of 16.78 and an above-average risk rating relative to its category. Furthermore, the fund is showing a negative alpha of -5.08 and a beta of 2.87, reflecting considerable sensitivity to rate fluctuations. While the 20-year target duration strategy tracks its underlying index effectively, the overall volatility profile means investors must have a high tolerance for drawdown if they are treating this as anything other than a targeted duration instrument.
When analyzing target-duration vehicles like XTWY for our institutional clients, my protocol focuses entirely on matching the exact duration profile against liability structures. The fund holds an average duration of approximately 20 years on U.S. Treasury securities, making it a precise tool for duration matching rather than a simple momentum play. Analysts reviewing this product should verify the 30-day SEC yield (sitting at 5.30% as of mid-2026) against prevailing yield curve dynamics and ensure that client mandates can handle the 'Aggressive' Morningstar risk classification before execution.
Explore plasma cleansing, somatic organ swaps, and BCI.